Tushar Samdani
Memorial Sloan Kettering Cancer Center
8 Papers
2 Citations
Tushar Samdani is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 5, co-authored 7 publications.
Chat about Author
Papers
Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
Tushar Samdani,Molly Schultheis,Zsofia K. Stadler,Jinru Shia,Tiffany T. Fancher,Justine Misholy,Martin R. Weiser,Garrett M. Nash +7 more
TL;DR: Pat age, length of bowel resected, lymph node ratio, perineural invasion, tumor size, and tumor location were significant predictors of lymph nodes yield, however, when controlling for surgical and pathologic factors, mismatch repair protein expression did not predict lymph node yield.
Is interval appendectomy indicated after non-operative management of acute appendicitis in patients with cancer? A retrospective review from a single institution.
Tushar Samdani,Tiffany T. Fancher,Frederic M. Pieracci,Soumitra R. Eachempati,Laila Rashidi,Garrett M. Nash +5 more
TL;DR: Among NOM patients at a cancer center at IHA for AA, recurrent AA was early (< 4 months) but uncommon, and IA should be offered to those with recurrent symptoms, but appears to have a very limited role after several months of asymptomatic follow-up.
9
Right Colectomy Procedure Guide
Kelly Olino,Tushar Samdani,Julio Garcia-Aguilar +2 more
- 01 Jan 2015
TL;DR: This chapter outlines the technique of robotic right hemicolectomy, which has been successfully used in over 100 patients and can serve as an alternative platform for the minimally invasive approach.
1
Laparoscopic Left Colectomy
Tushar Samdani,Julio Garcia-Aguilar +1 more
- 01 Jan 2015
TL;DR: The key operative steps necessary to a successful laparoscopic left colectomy are discussed, highlighting anatomical and preoperative considerations, key factors of the operative technique, and postoperative management and its complications.
1
Reappraisal of screening strategy in hepatitis B surface antigen-negative blood donors: Correlation with hepatitis B virus-DNA quantification
TL;DR: HBV-DNA should be implemented as a screening test of the blood donors to prevent TAHBV infection without potential donor rejection.